Cantor Fitzgerald analyst, Brandon Folkes, reiterated his Overweight rating on shares of BioDelivery Sciences International (NASDAQ: BDSI) after Symphony Health ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE